The methods behind transgenic plant production: a review

Jasmin Šutković, Nour Hamad, Petar Glamočlija


The ability to insert a gene into a plant’s nuclear or chloroplast genome enables the transformation of higher plants (e.g. tobacco, Arabidopsis thaliana, potato, tomato, and banana) into Bioreactors for the production of plant-derived pharmaceuticals. Biopharmaceuticals are generally produced on a commercial basis by scale fermentation in bacteria, yeast, or animal cells. Several plant-derived pharmaceuticals have undergone clinical trials and are close to market authorization, with antibodies and vaccines being the front runners. Plant-derived vaccines have been produced using recombinant plant viruses as transgenic expression vectors and Agrobacterium tumefaciens transformation systems. During the last decade, several efficient plant-based expression systems have been examined, and more than 100 recombinant proteins, including plant-derived vaccine antigens. Besides, regulatory protocols are slowing down production. Industry requirements and public acceptance of the technology are important aspects in establishing successful products. This paper reviews the current status of development in the area of biopharmaceuticals and vaccines produced from transgenic plants.


Plant-derived vaccines, Micro-injection, Biopharming, Agrobacterium

Full Text:



Sinclair, T.R., L.C. Purcell, and C.H. Sneller, Crop transformation and the challenge to increase yield potential. Trends in plant science, 2004. 9(2): p. 70-75.

Mihaliak, C.A., et al. Development of plant cell produced vaccines for animal health applications. in Proceedings of the 108th annual meeting of the United States Animal Health Association. 2005.

Tiwari, S., et al., Plants as bioreactors for the production of vaccine antigens. Biotechnology advances, 2009. 27(4): p. 449-467.

Burnett, M.J. and A.C. Burnett, Therapeutic recombinant protein production in plants: Challenges and opportunities. Plants, People, Planet, 2020. 2(2): p. 121-132.

Sainsbury, F. and G.P. Lomonossoff, Transient expressions of synthetic biology in plants. Current opinion in plant biology, 2014. 19: p. 1-7.

Schillberg, S., R. Fischer, and N. Emans, Molecular farming of recombinant antibodies in plants. Cellular and Molecular Life Sciences CMLS, 2003. 60(3): p. 433-445.

Peeters, K., et al., Production of antibodies and antibody fragments in plants. Vaccine, 2001. 19(17-19): p. 2756-2761.

Sijmons, P.C., et al., Production of correctly processed human serum albumin in transgenic plants. Bio/technology, 1990. 8(3): p. 217-221.

Hiatt, A., R. Caffferkey, and K. Bowdish, Production of antibodies in transgenic plants. Nature, 1989. 342(6245): p. 76-78.

Floss, D.M., D. Falkenburg, and U. Conrad, Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Transgenic research, 2007. 16(3): p. 315-332.

Giddings, G., et al., Transgenic plants as factories for biopharmaceuticals. Nat Biotechnol, 2000. 18(11): p. 1151-5.

Sartaj Sohrab, S., et al., Recent development and future prospects of plant-based vaccines. Current drug metabolism, 2017. 18(9): p. 831-841.

Donini, M. and C. Marusic, Current state-of-the-art in plant-based antibody production systems. Biotechnology letters, 2019. 41(3): p. 335-346.

Rybicki, E.P., Plant molecular farming of virus‐like nanoparticles as vaccines and reagents. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2020. 12(2): p. e1587.

De Block, M., et al., Expression of foreign genes in regenerated plants and in their progeny. The EMBO Journal, 1984. 3(8): p. 1681-1689.

Daniell, H., Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnology Journal, 2006. 1(10): p. 1071-1079.

Hayford, M.B., et al., Development of a plant transformation selection system based on expression of genes encoding gentamicin acetyltransferases. Plant physiology, 1988. 86(4): p. 1216-1222.

Çiftçi, Y.O., Transgenic Plants: Advances and Limitations. 2012: BoD–Books on Demand.

Gao, X., K.-S. Kim, and D. Liu, Nonviral gene delivery: what we know and what is next. The AAPS journal, 2007. 9(1): p. E92-E104.

Sun, H.-J., et al., A highly efficient transformation protocol for Micro-Tom, a model cultivar for tomato functional genomics. Plant and Cell Physiology, 2006. 47(3): p. 426-431.

Deshayes, A., L. Herrera‐Estrella, and M. Caboche, Liposome‐mediated transformation of tobacco mesophyll protoplasts by an Escherichia coli plasmid. The EMBO Journal, 1985. 4(11): p. 2731-2737.

Umemoto, Y., et al., Gene transfer to mouse testes by electroporation and its influence on spermatogenesis. Journal of andrology, 2005. 26(2): p. 264-271.

Klein, T.M., et al., High-velocity microprojectiles for delivering nucleic acids into living cells. Nature, 1987. 327(6117): p. 70-73.

Laere, E., et al., Plant-Based Vaccines: Production and Challenges. Journal of Botany, 2016.

Griesbach, R., Chromosome-mediated transformation via microinjection. Plant Science, 1987. 50(1): p. 69-77.

Kaeppler, H., et al., Silicon carbide fiber-mediated stable transformation of plant cells. Theoretical and applied genetics, 1992. 84(5-6): p. 560-566.

Shou, H., R.G. Palmer, and K. Wang, Irreproducibility of the soybean pollen-tube pathway transformation procedure. Plant molecular biology reporter, 2002. 20(4): p. 325-334.

Radford, A., et al., Liposome-mediated genetic transformation of Neurospora crassa. Molecular and General Genetics MGG, 1981. 184(3): p. 567-569.

Ma, H. and G. Chen, Gene transfer technique. Nature and Science, 2005. 3(1): p. 25-31.

Sakoda, T., et al., Calcium phosphate coprecipitation greatly enhances transduction of cardiac myocytes and vascular smooth muscle cells by lentivirus vectors. Experimental & Clinical Cardiology, 2007. 12(3): p. 133.

Warden, D. and H. Thorne, The infectivity of polyoma virus DNA for mouse embryo cells in the presence of diethylaminoethyl-dextran. Journal of General Virology, 1968. 3(3): p. 371-377.

Bertini, E., et al., Regeneration of plants from embryogenic callus-derived protoplasts of Garganega and Sangiovese grapevine (Vitis vinifera L.) cultivars. Plant Cell, Tissue and Organ Culture (PCTOC), 2019. 138(2): p. 239-246.

McBride, K.E., et al., Amplification of a chimeric Bacillus gene in chloroplasts leads to an extraordinary level of an insecticidal protein in tobacco. Bio/technology, 1995. 13(4): p. 362-365.

Kwak, S.-Y., et al., Chloroplast-selective gene delivery and expression in planta using chitosan-complexed single-walled carbon nanotube carriers. Nature Nanotechnology, 2019. 14(5): p. 447-455.

Bartlett, J.G., et al., High-throughput Agrobacterium-mediated barley transformation. Plant Methods, 2008. 4(1): p. 1-12.

Smith, E.F. and C.O. Townsend, A plant-tumor of bacterial origin. Science, 1907. 25(643): p. 671-673.

Zambryski, P., et al., Ti plasmid vector for the introduction of DNA into plant cells without alteration of their normal regeneration capacity. The EMBO journal, 1983. 2(12): p. 2143-2150.

Guo, M., et al., Agrobacterium-mediated horizontal gene transfer: Mechanism, biotechnological application, potential risk and forestalling strategy. Biotechnology advances, 2019. 37(1): p. 259-270.

Gelvin, S.B., Agrobacterium and plant genes involved in T-DNA transfer and integration. Annual review of plant biology, 2000. 51(1): p. 223-256.

Narusaka, M., et al., The floral inoculating protocol: a simplified Arabidopsis thaliana transformation method modified from floral dipping. Plant Biotechnology, 2010. 27(4): p. 349-351.

Sharma, M.K., et al., A simple and efficient Agrobacterium-mediated procedure for transformation of tomato. Journal of biosciences, 2009. 34(3): p. 423-433.

Liu, Z., et al., The novel use of a combination of sonication and vacuum infiltration in Agrobacterium-mediated transformation of kidney bean (Phaseolus vulgaris L.) with lea gene. Molecular Breeding, 2005. 16(3): p. 189.

Thomas, D.R., et al., Evolution of plant-made pharmaceuticals. International Journal of Molecular Sciences, 2011. 12(5): p. 3220-3236.

Lyle, C., Immunostimulatory Effects of Antigen-Conjugated InP/ZnS Quantum Dot Nanoparticles in an Avian Model. 2018.

Mukhlish, M.Z.B., Development of flexible ceramic nanofiber membranes for energy and environmental applications. 2018, Dissertation, Kagoshima University.

Shama, L. and R.K. Peterson, The benefits and risks of producing pharmaceutical proteins in plants. Risk Management Matters, 2004. 2(4): p. 28-33.

Kwon, K.-C., et al., Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells. Advanced drug delivery reviews, 2013. 65(6): p. 782-799.

Iqbal, R., et al., Vaccination and Biopharming Technology. J Biomol Res Ther 7: 168. doi: 10.4172/2167-7956.1000168

Valkova, R., E. Apostolova, and S. Naimov, Plant molecular farming: opportunities and challenges. Journal of the Serbian Chemical Society, 2013. 78(3): p. 407-415.

Schillberg, S., et al., Critical analysis of the commercial potential of plants for the production of recombinant proteins. Frontiers in plant science, 2019. 10: p. 720.

Zimran, A., et al., Pivotal trial with plant cell–expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. Blood, The Journal of the American Society of Hematology, 2011. 118(22): p. 5767-5773.

Hellwig, S., et al., Plant cell cultures for the production of recombinant proteins. Nature biotechnology, 2004. 22(11): p. 1415-1422.

Karg, S.R. and P.T. Kallio, The production of biopharmaceuticals in plant systems. Biotechnology advances, 2009. 27(6): p. 879-894.

Conley, A.J., et al., Optimization of elastin‐like polypeptide fusions for expression and purification of recombinant proteins in plants. Biotechnology and bioengineering, 2009. 103(3): p. 562-573.

Guerrero-Andrade, O., et al., Expression of the Newcastle disease virus fusion protein in transgenic maize and immunological studies. Transgenic research, 2006. 15(4): p. 455-463.

Shafaghi, M., et al., Transient expression of biologically active anti-rabies virus monoclonal antibody in tobacco leaves. Iranian journal of biotechnology, 2018. 16(1).

Rattanapisit, K., et al., Plant-produced anti-Enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection. Plants, 2019. 8(12): p. 560.

Rattanapisit, K., et al., Structural and in vitro functional analyses of novel plant-produced anti-human PD1 antibody. Scientific reports, 2019. 9(1): p. 1-10.

Zhang, X., et al., Agrobacterium-mediated transformation of Arabidopsis thaliana using the floral dip method. Nature protocols, 2006. 1(2): p. 641.

Shanmugaraj, B., C.J. I Bulaon, and W. Phoolcharoen, Plant molecular farming: a viable platform for recombinant biopharmaceutical production. Plants, 2020. 9(7): p. 842.

Qiu, X., et al., Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature, 2014. 514(7520): p. 47-53.

Liew, P.S. and M. Hair-Bejo, Farming of plant-based veterinary vaccines and their applications for disease prevention in animals. Advances in virology, 2015. 2015.

Yusibov, V.M. and T.G. Mamedov, Plants as an alternative system for expression of vaccine antigens. Proc. ANAS (Biol. Sci.), 2010. 65: p. 195-200.

Rybicki, E.P., Plant‐made vaccines for humans and animals. Plant biotechnology journal, 2010. 8(5): p. 620-637.

Shahid, N. and H. Daniell, Plant‐based oral vaccines against zoonotic and non‐zoonotic diseases. Plant biotechnology journal, 2016. 14(11): p. 2079-2099.

Shanmugaraj, B., A. Malla, and W. Phoolcharoen, Emergence of novel coronavirus 2019-nCoV: need for rapid vaccine and biologics development. Pathogens, 2020. 9(2): p. 148.

Rosales-Mendoza, S., Will plant-made biopharmaceuticals play a role in the fight against COVID-19? 2020, Taylor & Francis.

Shanmugaraj, B., et al., Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol, 2020. 38(1): p. 10-18.

Capell, T., et al., Potential applications of plant biotechnology against SARS-CoV-2. Trends in Plant Science, 2020.

Srilekha K, Kamlaja T, Rajeswari K, Lakshmi VV. Chapter-1 Edible Vaccines. Chief Editor Dr. RK Naresh. 2019:1.

Rosales-Mendoza, S., et al., Transplastomic plants yield a multicomponent vaccine against cysticercosis. Journal of Biotechnology, 2018. 266: p. 124-132.

Bosch, D. and A. Schots, Plant glycans: friend or foe in vaccine development? Expert review of vaccines, 2010. 9(8): p. 835-842.

Penney, C.A., et al., Plant-made vaccines in support of the Millennium Development Goals. Plant cell reports, 2011. 30(5): p. 789-798.

Lal, P., et al., Edible vaccines: current status and future. Indian journal of medical microbiology, 2007. 25(2): p. 93.

Gutierrez-Valdes, N., et al., Hairy Root Cultures—A Versatile Tool With Multiple Applications. Frontiers in Plant Science, 2020. 11.

Chen, M., et al., Modification of plant N‐glycans processing: The future of producing therapeutic protein by transgenic plants. Medicinal research reviews, 2005. 25(3): p. 343-360.

Kolotilin, I., et al., Plant-based solutions for veterinary immunotherapeutics and prophylactics. Veterinary research, 2014. 45(1): p. 1-12.



  • There are currently no refbacks.

Copyright (c) 2021 Authors

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN: 2303-4521

Digital Object Identifier DOI: 10.21533/pen

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License